We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
REVOLADE (Novartis Pharmaceuticals Australia Pty Ltd)
Product name
REVOLADE
Date registered
Evaluation commenced
Decision date
Approval time
192 (255 working days)
Active ingredients
eltrombopag olamine
Registration type
EOI
Indication
adult patients with ITP who have had an inadequate response or are intolerant to corticosteroids and immunoglobulins;